Part 4 of 7
The most serious risk is a seizure. It is rare.
The most serious risk of TMS is a seizure during a treatment session. It happens about once in every 30,000 sessions.
Counted by person, that is about 1 person in every 1,400 treated. The picture below shows what that looks like.
When a seizure has happened during TMS, it has been brief and has stopped on its own. It does not mean the person has epilepsy.
We lower the risk by asking about seizures, medicines, alcohol and sleep before you start, and a trained technician is with you for every session.
The evidence
Human evidence
In a Clinical TMS Society survey, 18 seizures were reported across 586,656 treatment sessions and 25,526 patients. That is 0.31 seizures per 10,000 sessions (95% CI 0.18 to 0.48) and 0.71 per 1,000 patients (95% CI 0.42 to 1.11). Rates were lower with standard figure-8 coils than with deep H-coils.
For comparison, in a surveillance study of the antidepressant bupropion SR at standard doses, 3 of 3,100 patients had a seizure, which is about 1 in 1,000.
Expert safety guidelines describe TMS-related seizures as self-limited, with no evidence that they lead to epilepsy.
- Taylor et al. 2021, Brain Stimulation
- Rossi et al. 2021, Clinical Neurophysiology (safety guidelines)
- Dunner et al. 1998, J Clin Psychiatry (bupropion SR)